ArticleFEBS open bio2020

The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice.

Zi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.